Organigram Holdings Stock Earnings Per Share
| OGI Stock | CAD 2.58 0.02 0.78% |
OrganiGram Holdings fundamentals help investors to digest information that contributes to OrganiGram Holdings' financial success or failures. It also enables traders to predict the movement of OrganiGram Stock. The fundamental analysis module provides a way to measure OrganiGram Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OrganiGram Holdings stock.
OrganiGram |
OrganiGram Holdings Company Earnings Per Share Analysis
OrganiGram Holdings' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current OrganiGram Holdings Earnings Per Share | (2.51) X |
Most of OrganiGram Holdings' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OrganiGram Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, OrganiGram Holdings has an Earnings Per Share of -2.51 times. This is 129.99% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The earnings per share for all Canada stocks is 180.45% higher than that of the company.
OrganiGram Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OrganiGram Holdings' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OrganiGram Holdings could also be used in its relative valuation, which is a method of valuing OrganiGram Holdings by comparing valuation metrics of similar companies.OrganiGram Holdings is currently under evaluation in earnings per share category among related companies.
OrganiGram Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0556 | ||||
| Profit Margin | (1.54) % | ||||
| Operating Margin | (0.44) % | ||||
| Current Valuation | 203.58 M | ||||
| Shares Outstanding | 103 M | ||||
| Shares Owned By Insiders | 27.32 % | ||||
| Shares Owned By Institutions | 8.96 % | ||||
| Number Of Shares Shorted | 979.64 K | ||||
| Price To Book | 1.07 X | ||||
| Price To Sales | 1.85 X | ||||
| Revenue | 145.81 M | ||||
| Gross Profit | 31.57 M | ||||
| EBITDA | (15.21 M) | ||||
| Net Income | (229.48 M) | ||||
| Cash And Equivalents | 44.78 M | ||||
| Cash Per Share | 0.23 X | ||||
| Total Debt | 3.36 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 5.15 X | ||||
| Book Value Per Share | 3.18 X | ||||
| Cash Flow From Operations | (36.21 M) | ||||
| Short Ratio | 1.32 X | ||||
| Earnings Per Share | (2.51) X | ||||
| Price To Earnings To Growth | 0.04 X | ||||
| Target Price | 3.86 | ||||
| Number Of Employees | 984 | ||||
| Beta | 1.1 | ||||
| Market Capitalization | 263.68 M | ||||
| Total Asset | 577.11 M | ||||
| Retained Earnings | (289.93 M) | ||||
| Working Capital | 166.34 M | ||||
| Net Asset | 577.11 M |
About OrganiGram Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OrganiGram Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OrganiGram Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OrganiGram Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |